FDA
approval
· 2020-09-02
FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approves Sun Pharmaceutical Industries' generic calcipotriene and betamethasone dipropionate topical combination for plaque psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)